# Glycopyrrolate

NDC: 25021-796
Generic name: Glycopyrrolate
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20241015

FDA application: ANDA210083

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-796"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-796
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55930f87-8964-43b1-b790-c1e6dd2602d2